Ubinuclein, a novel nuclear protein interacting with cellular and viral transcription factors

被引:38
作者
Aho, S
Buisson, M
Pajunen, T
Ryoo, YW
Giot, JF
Gruffat, H
Sergeant, A
Uitto, J
机构
[1] Thomas Jefferson Univ, Jefferson Med Coll, Dept Dermatol & Cutaneous Surg, Philadelphia, PA 19107 USA
[2] Thomas Jefferson Univ, Jefferson Inst Mol Med, Philadelphia, PA 19107 USA
[3] INSERM, U412, Lab Virol Humaine, F-69346 Lyon, France
关键词
Epstein-Barr virus; epidermis; protein-protein interaction; keratinocyte differentiation; chromosome; 16;
D O I
10.1083/jcb.148.6.1165
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The major target tissues for Epstein-Barr virus (EBV) infection are B lymphocytes and epithelial cells of the oropharyngeal zone. The product of the EBV BZLF1 early gene, EB1, a member of the basic leucine-zipper family of transcription factors, interacts with both viral and cellular promoters and transcription factors, modulating the reactivation of latent EBV infection. Here, we characterize a novel cellular protein interacting with the basic domains of EB1 and c-Jun, and competing of their binding to the AP1 consensus site. The transcript is present in a wide variety of human adult, fetal, and tumor tissues, and the protein is detected in the nuclei throughout the human epidermis and as either grainy or punctuate nuclear staining in the cultured keratinocytes, The overexpression of tagged cDNA constructs in keratinocytes revealed that the NH2 terminus is essential for the nuclear localization, while the central domain is responsible for the interaction with EB1 and for the phenotype of transfected keratinocytes similar to terminal differentiation, The gene was identified in tail-to-tail orientation with the periplakin gene (PPL) in human chromosome 16p13.3 and in a syntenic region in mouse chromosome 16, We designated this novel ubiquitously expressed nuclear protein as ubinuclein and the corresponding gene as UBN1.
引用
收藏
页码:1165 / 1176
页数:12
相关论文
共 43 条
  • [1] cDNA cloning, mRNA expression, and chromosomal mapping of human and mouse periplakin genes
    Aho, S
    McLean, WHI
    Li, KH
    Uitto, J
    [J]. GENOMICS, 1998, 48 (02) : 242 - 247
  • [2] Human periplakin: Genomic organization in a clonally unstable region of chromosome 16p with an abundance of repetitive sequence elements
    Aho, S
    Rothenberger, K
    Tan, EML
    Ryoo, YW
    Cho, BH
    McLean, WHI
    Uitto, J
    [J]. GENOMICS, 1999, 56 (02) : 160 - 168
  • [3] AITAHMED O, 1987, DEV BIOL, V122, P153
  • [4] THE YEMANUCLEIN-ALPHA - A NEW DROSOPHILA DNA-BINDING PROTEIN-SPECIFIC FOR THE OOCYTE NUCLEUS
    AITAHMED, O
    BELLON, B
    CAPRI, M
    JOBLET, C
    THOMASDELAAGE, M
    [J]. MECHANISMS OF DEVELOPMENT, 1992, 37 (1-2) : 69 - 80
  • [5] Gapped BLAST and PSI-BLAST: a new generation of protein database search programs
    Altschul, SF
    Madden, TL
    Schaffer, AA
    Zhang, JH
    Zhang, Z
    Miller, W
    Lipman, DJ
    [J]. NUCLEIC ACIDS RESEARCH, 1997, 25 (17) : 3389 - 3402
  • [6] Activation of the Epstein-Barr virus transcription factor BZLF1 by 12-O-tetradecanoylphorbol-13-acetate-induced phosphorylation
    Baumann, M
    Mischak, H
    Dammeier, S
    Kolch, W
    Gires, O
    Pich, D
    Zeidler, R
    Delecluse, HJ
    Hammerschmidt, W
    [J]. JOURNAL OF VIROLOGY, 1998, 72 (10) : 8105 - 8114
  • [7] Gene activation by histone and factor acetyltransferases
    Berger, SL
    [J]. CURRENT OPINION IN CELL BIOLOGY, 1999, 11 (03) : 336 - 341
  • [8] Activation of RNA polymerase II transcription
    Berk, AJ
    [J]. CURRENT OPINION IN CELL BIOLOGY, 1999, 11 (03) : 330 - 335
  • [9] Normalization and subtraction: Two approaches to facilitate gene discovery
    Bonaldo, MDF
    Lennon, G
    Soares, MB
    [J]. GENOME RESEARCH, 1996, 6 (09): : 791 - 806
  • [10] Identification and characterization of a novel kind of nuclear protein occurring free in the nucleoplasm and in ribonucleoprotein structures of the "speckle" type
    Brandner, JM
    Reidenbach, S
    Kuhn, C
    Franke, WW
    [J]. EUROPEAN JOURNAL OF CELL BIOLOGY, 1998, 75 (04) : 295 - 308